Mahmoud A. ElSohly, PhD

Scientific Advisor

Dr. ElSohly is one of the world’s foremost experts in cannabis science. A Research Professor at the National Center for Natural Products Research and Professor of Pharmaceutics, School of Pharmacy, University of Mississippi (UM), he is also President and Laboratory Director of ElSohly Laboratories (ELI) in Oxford, Mississippi. At UM, Dr. ElSohly also serves as the Director of the Marijuana Project under contract with the National Institute on Drug Abuse (NIDA). He holds more than 30 patents covering several processes and drug discovery topics in the area of natural products and cannabis research. A graduate of Pharmacy from the University of Cairo, Dr. ElSohly obtained his PhD in Pharmacognosy from the University of Pittsburgh. He has authored or co-authored more than 300 scientific publications in peer reviewed journals and regularly presents at national and international scientific conferences.

Donald I. Abrams, MD

Scientific Advisor, Chief Hematology/Oncology at UCSF

Dr. Donald I. Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. Dr. Abrams provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative therapies including mind-body treatments, botanical therapies, medical use of marijuana and traditional Chinese medicine herbal therapies.

In addition to his role at the Osher Center, Abrams continues to practice general oncology at Zuckerberg San Francisco General Hospital, where he was chief of Hematology-Oncology from 2003 to 2017. Previously at the forefront in HIV/AIDS research and treatment, Abrams completed a fellowship in integrative medicine at the University of Arizona in 2004 and subsequently stepped down from HIV practice to devote more time to integrative oncology. He continues to research the health effects of medical cannabis. He co-edited the textbook Integrative Oncology, published by Oxford University Press, with Dr. Andrew Weil. In 2010, Dr. Abrams served as president of the Society for Integrative Oncology.


Jeffrey Goldberg, MD, PhD

Ophthalmology Scientific Advisor

Dr. Goldberg is the Professor and Chair of Ophthalmology and Director of the Spencer Center for Vision Research at the Byers Eye Institute at Stanford University. He received his undergraduate degree, magna cum laude, from Yale University, and his M.D./Ph.D. from Stanford University. Dr. Goldberg is a distinguished researcher investigating neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies. He received the Cogan award from the Association for Research in Vision and Ophthalmology in 2012 and was elected in 2010 to the American Society of Clinical Investigation, an honorary society of physician scientists. Dr. Goldberg directs an NIH-funded research laboratory and has developed significant expertise with implementing clinical trials addressing optic nerve neuroprotection and regeneration. His laboratory is developing novel nanotherapeutic approaches for eye repair in addition to validating biomarkers associated with neuroprotection.

Louis Pasquale, MD, FARVO

Ophthalmology Scientific Advisor

Dr. Pasquale is the Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai in New York City. He is a Phi Beta Kappa graduate of Manhattan College and earned his M.D. degree from SUNY Stony Brook where he was selected for Alpha Omega Alpha, the national honor medical society. Dr. Pasquale is Site Chair of the Department of Ophthalmology at Mt. Sinai Hospital and Vice Chair of Translational Ophthalmology Research for the Mount Sinai Healthcare System. He currently serves as Glaucoma Trustee for the Association of Research in Vision and Ophthalmology (ARVO) and is a member of the National Institute of Health’s National Advisory Eye Council. He is a member of multiple editorial boards, including the Journal of Glaucoma, the American Journal of Ophthalmology, and Ophthalmology Glaucoma. Dr. Pasquale is an NIH Principal Investigator with continuous support since 2006.

Robert Ritch, MD

Ophthalmology Scientific Advisor

Dr. Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Clinical Professor of Ophthalmology at the Mt. Sinai Medical School and Surgeon Director Emeritus and Chief of Glaucoma Services at the New York Eye & Ear Infirmary of Mount Sinai, New York City. Dr. Ritch received his undergraduate degree from Harvard College and an M.D. degree from the Albert Einstein College of Medicine. He founded the Glaucoma Foundation and has contributed to multiple textbooks of ophthalmology, including more than 1500 published medical and scientific articles and abstracts. He has given over 50 named lectures and received 60 national and international awards. Dr. Ritch has served on the editorial boards of a number of professional journals including the Journal of Glaucoma, the Asia-Pacific Journal of Ophthalmology, and the Archives of Ophthalmology. He is a Diplomate of the American Board of Ophthalmology as well as a Fellow of the American Academy of Ophthalmology and the Royal College of Ophthalmology.